5Stewart L, Katial R. Exhaled nitric oxide[J]. Immunol Allergy Clin North Am, 2007,27(4) : 571-586.
6Hunt J F, Fang K, Malik R, et al. Endogenous airway acidification: implications for asthma pathophysiology[J]. Am J Respir Crit Care Med, 2000,161 (3): 694-699.
7Liu L, Urban P, Hunt J F, etal. Changes in exhaled nitric oxide and breath pH during fluticasone wean in asthma [J ]. Respiration,2010,79(3) :193-199.
8Majid H, Kao C. Utility of exhaled nitric oxide in the diagnosis and management of asthma[J]. Curr Opin Pulm Med, 2010, 6 (1) :42-47.
9Bernstein J A, Davis B, Alvarez-Puebla M J, et al. Is exhaled nitric oxide a useful adjunctive test for assessing asthma[J]. J Asthma,2009,46(9) :955-960.
10Hewitt R S, Modrich C M, Cowan J O, et al. Outcomes using exhaled nitric oxide measurements as an adjunct to primary care asthma management[J]. Prim Care Respir J,2009,8(4):320- 327.
4Lorrot M, Moulin F, Coste J, et al. Procalcitonin in pediatric e- mergencies: comparison with c-reactive, interleukin 6 and inter- ferom alpha in the differentiation between bacterial and infections [J]. Press Med,2000,29(3) :128 -134.
5Akalin A, Alatas O, Colak O. Relation of plasma homocysteine levels to atherosclerotic vascular disease and inflammation marker in type 2 diabetic patients[J]. Eur J Endoerinol,2008,158 ( 1 ) : 47 - 52.
6Aronow WS, Ahn G, Gulstein H. Increased plasma homocysteine is an independent predictor of new atherothrom botic brain infarc- tionin older person[J]. Am J Cardiol,2000,86(5) :585 -586.
7Tsalik EL, Jaggers LB, Glickman SW, et al. Biocriminative value of inflammatory biomarkers for suspected sepsis[J]. Emerg Med, 2012,43 ( 1 ) :97 - 106.
8Yamamoto K, Rose-Juhn S. Therapeutic blockade of interleukin-6 in chronic inflammary disease [ J ]. Clin Pharmacol Ther, 2012,91 (4) :574 -576.
9Tschaikowsky K, Hedwig-Geissing M, Braun GG,et al. Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis [ J ]. J Crit Care, 2011 ,26(1) :54 -64.
